Recombinase-Dependent Mouse Lines for Chemogenetic Activation of Genetically Defined Cell Types.

Chemogenetic technologies, including the mutated human Gq-coupled M3 muscarinic receptor (hM3Dq), have greatly facilitated our ability to directly link changes in cellular activity to altered physiology and behavior. Here, we extend the hM3Dq toolkit with recombinase-responsive mouse lines that permit hM3Dq expression in virtually any cell type. These alleles encode a fusion protein designed to increase effective expression levels by concentrating hM3Dq to the cell body and dendrites. To illustrate their broad utility, we targeted three different genetically defined cell populations: noradrenergic neurons of the compact, bilateral locus coeruleus and two dispersed populations, Camk2a+ neurons and GFAP+ glia. In all three populations, we observed reproducible expression and confirmed that activation of hM3Dq is sufficient to dose-dependently evoke phenotypic changes, without extreme phenotypes associated with hM3Dq overexpression. These alleles offer the ability to non-invasively control activity of diverse cell types to uncover their function and dysfunction at any developmental stage.

[1]  S. Sternson,et al.  A FLEX Switch Targets Channelrhodopsin-2 to Multiple Cell Types for Imaging and Long-Range Circuit Mapping , 2008, The Journal of Neuroscience.

[2]  A. Joyner,et al.  Two lineage boundaries coordinate vertebrate apical ectodermal ridge formation. , 2000, Genes & development.

[3]  T. Hope,et al.  Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors , 1999, Journal of Virology.

[4]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[5]  Russell S. Ray,et al.  Activity of Raphé Serotonergic Neurons Controls Emotional Behaviors. , 2015, Cell reports.

[6]  B. Sauer.  Manipulation of transgenes by site-specific recombination: use of Cre recombinase. , 1993, Methods in enzymology.

[7]  J. McCall,et al.  CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety , 2015, Neuron.

[8]  K. Deisseroth,et al.  Tuning arousal with optogenetic modulation of locus coeruleus neurons , 2010, Nature Neuroscience.

[9]  G. Stöcklin,et al.  Synthesis of n.c.a. carbon-11 labelled clozapine and its major metabolite clozapine-N-oxide and comparison of their biodistribution in mice. , 1994, Nuclear medicine and biology.

[10]  Philippe Soriano,et al.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. , 1991, Genes & development.

[11]  Marina Gertsenstein,et al.  Developmental and adult phenotyping directly from mutant embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[12]  G. Martin,et al.  Analysis of Fgf8 gene function in vertebrate development. , 1997, Cold Spring Harbor symposia on quantitative biology.

[13]  B. Roth,et al.  DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. , 2015, Annual review of pharmacology and toxicology.

[14]  M. Nicolelis,et al.  Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled Receptors , 2009, Neuron.

[15]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[16]  B. Roth,et al.  The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro , 2003, Neuroscience.

[17]  Bryan L. Roth,et al.  Modulation of the autonomic nervous system and behaviour by acute glial cell Gq protein‐coupled receptor activation in vivo , 2013, The Journal of physiology.

[18]  S. Robertson,et al.  Developmental origins of central norepinephrine neuron diversity , 2013, Nature Neuroscience.

[19]  B. Roth,et al.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand , 2007, Proceedings of the National Academy of Sciences.

[20]  B. Roth,et al.  DREADD: A Chemogenetic GPCR Signaling Platform , 2014, The international journal of neuropsychopharmacology.

[21]  S. Robertson,et al.  Expanding the power of recombinase-based labeling to uncover cellular diversity , 2015, Development.

[22]  M. Fanselow,et al.  α1 Subunit-Containing GABA Type A Receptors in Forebrain Contribute to the Effect of Inhaled Anesthetics on Conditioned Fear , 2005, Molecular Pharmacology.

[23]  P. Chambon,et al.  A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse , 2003, Nature Biotechnology.

[24]  Reynaldo Sequerra,et al.  High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP , 2000, Nature Genetics.

[25]  J. T. Williams,et al.  Membrane properties of rat locus coeruleus neurones , 1984, Neuroscience.

[26]  David J. Anderson,et al.  Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain , 1996, Cell.

[27]  C. S. Raymond,et al.  High-Efficiency FLP and ΦC31 Site-Specific Recombination in Mammalian Cells , 2007, PloS one.

[28]  K. McCarthy,et al.  Characterization of astrocyte‐specific conditional knockouts , 2007, Genesis.

[29]  R. Callister,et al.  Pacemaker currents in mouse locus coeruleus neurons , 2010, Neuroscience.

[30]  P. Holmes,et al.  Galanin mediates features of neural and behavioral stress resilience afforded by exercise , 2015, Neuropharmacology.

[31]  Frank Buchholz,et al.  Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice , 2009, Disease Models & Mechanisms.